Theruvath, Johanna <br/><br/>
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.  [electronic resource] 

 -  Nature medicine  05 2020 
 - 712-719 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1546-170X 
<br/><br/><label>Standard No.: </label>10.1038/s41591-020-0821-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>B7 Antigens--immunology<br/>Brain--drug effects<br/>Brain Neoplasms--immunology<br/>Cancer Vaccines--administration & dosage<br/>Cells, Cultured<br/>Child, Preschool<br/>Female<br/>Fetus--pathology<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Infant<br/>Injections, Intraventricular<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Receptors, Chimeric Antigen--administration & dosage<br/>Rhabdoid Tumor--immunology<br/>T-Lymphocytes--immunology<br/>Teratoma--immunology<br/>Xenograft Model Antitumor Assays